Transce3nd’s MetLife MET Stock Holding History

Transce3nd’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-134	Closed	-$10.8K	–	748
2025 Q2	$10.8K	Buy	134 +37	+38%	+$2.85K	﹤0.01%	555
2025 Q1	$7.79K	Sell	97 -222	-70%	-$18.5K	﹤0.01%	624
2024 Q4	$26.1K	Buy	+319	New	+$26.5K	0.01%	496

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Transce3nd's MET Position: Q3 2025 in Review

Transce3nd sold out of MetLife (MET) in Q3 2025, closing a stake of 134 shares — an estimated $10.8K sold.

Transce3nd first reported a position in MET in Q4 2024 and held it in 3 quarters. The position peaked at $26.1K in Q4 2024. 1,363 funds tracked by Wall St. Rank hold MET as of Q3 2025.

Transce3nd reported no remaining MetLife position as of Q3 2025 after selling out during the quarter.
Transce3nd sold 134 MetLife shares in Q3 2025, an estimated $10.8K.
Transce3nd first reported a position in MetLife in Q4 2024 and held it in 3 quarters.
Transce3nd's MetLife position peaked at $26.1K in Q4 2024.
1,363 funds tracked by Wall St. Rank held MetLife as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.